Positive Technologies Uncovers Vulnerability in IDEMIA Biometric Identification Devices That Can Unlock Doors and Turnstiles

Positive Technologies announced today that its researchers have uncovered a critical vulnerability in IDEMIA biometric identification devices. When exploited, the vulnerability can allow criminals to unlock doors and turnstiles leading to protected areas within organizations, and disable access control systems.

Clinical Research Technology Leader RealTime Secures Growth Investment from LLR Partners

RealTime Software Solutions, LLC, a leader in cloud-based software solutions for the clinical research industry, today announced a significant growth investment from LLR Partners. The capital and resources from this partnership will be dedicated to helping accelerate the company’s growth, product innovation and delivery of world-class customer experiences.

Rho Promotes Mark Ubert to CFO

Global Digital Twin Market Research Report - Increasing Demand for Personalized Medical Therapies

The Digital Twin market growth is poised to be driven by the rising demand for personalized therapies and trend of digitization across the healthcare and medical segment.

PreOmics Announces Closing of Series B Financing to Accelerate Research, Development and Commercialization of Proteomics Tools and Consumables

PubHive Automates Duplicate Detection for European Medicine Agency’s MLM Data

PubHive’s AI-powered software-as-a-service platform enables drug safety and pharmacovigilance teams to automatically identify duplicate search hits from European Medicine Agency’s Medical Literature Monitoring (MLM) service and streamline ICSR reviews

Temedica Introduces Permea: First Analytics Platform Integrating Patient-Generated Health Data

ACM Presents PEARC22, July 10–14, in Boston

The ACM PEARC22 (Association of Computing Machinery, Practice and Experience in Advanced Research Computing) conference will be held at the Boston Park Plaza Hotel in Boston, Massachusetts, July 10–14, 2022.

Topography Health Launches with $27.5M Funding to Empower Community Physicians to Run Clinical Drug Trials

Topography Health, the world’s first full-stack clinical trials platform for community physicians, launched out of stealth this week to tackle mass scale clinical trial access: Backed by Bain Venture Capital and Andreesen Horowitz with $27.5M in funding, Topography is on a mission to expand access to clinical trials for both patients and their providers. By creating the largest network of community physicians and equipping them with the tools and staff they need to conduct medical research, Topography is making it possible for your family doctor to offer clinical drug trials as part of their practice. Research will not just be for potentially terminal illnesses, but also for moderate chronic illnesses, where the standard of care lags.

CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Formulation Projects

Quantum Dots & Upconverting Nanoparticles Provided by Alfa Chemistry Can Improve Medical Technology and Energy Research

Microarray Data Analysis Service Now Available by CD Genomics's Bioinformatics-Analysis Platform

The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. Recently, CD Genomics announced the launch of the Microarray Data Analysis service to help scientists discover the biological significance of microarray data and, at the same time, help reduce the time and cost of wet laboratory experiments and data generation.

Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service

The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information science, database construction, and management. Recently, the company announced the launch of biomarker and target discovery service for disease identification, early diagnosis and prevention, and monitoring during treatment.

BioIVT Launches GMP Grade Human AB Serum to Facilitate the Development and Manufacturing of Cell and Gene Therapies

This cell culture supplement can be used to manufacture both autologous and allogeneic cell therapies.

WuXi STA Launches its First Parenteral Formulation Manufacturing Line

DxCG Intelligence Celebrates 25th Anniversary, Launches Version 6.0 with Enhanced Clinical and Pharmaceutical Classification Systems

Cotiviti’s preeminent risk assessment and predictive modeling tool continues to aid in improving healthcare cost and quality

Protecting All Assets from All Cyber Attacks Is Unrealistic; Focus on Preventing the Unacceptable: Positive Technologies CEO

In a talk at the World Expo 2020 Dubai on Sunday, Positive Technologies CEO, Denis Baranov spoke about how protecting all assets from all cyberattacks is unrealistic, and suggested that organizations and industries instead take a new approach that specifically focuses on eliminating ‘unacceptable’ risks at every level.

CD ComputaBio Unveils Ligand-based Pharmacophore Model Service for Drug Design and Screening

CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering away at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company recently announced the launch of ligand-based pharmacophore model service for scientists to accelerate the drug candidate development process.

Creative Proteomics Lipidomics Launches Exosomes Lipidomics Service to Study the Biological Characteristics of Vesicles

Lipidomics, a division of Creative Proteomics, is committed to providing untargeted lipidomics services, targeted lipidomics services, metabolic flux analysis services, and lipidomics related services for research institutions, biotechnology and pharmaceutical companies. The company continues to accelerate lipidomics research to make contributions in the fields of biopharmaceuticals, population health, the food industry, etc. Creative Proteomics Lipidomics has recently announced the launch of Exosomes Lipidomics Service, which can help scientists understand vesicle biogenesis and function, identify lipid-based biomarkers and unravel their monitoring function in diseases.

GutFlora Omics Platform Launches Virome Sequencing Service to Investigate Gut Microbiota